[E2.0000] Reporting Requirements for Diseases and Conditions in Kentucky A brief summary of Kentucky’s reportable diseases, conditions, and abuse.

• Anthrax
• Botulism
• Brucellosis (multiple cases, temporally or spatially clustered)
• Diphtheria
• Hepatitis A, acute
• Measles
• Meningococcal infections
• Middle East Respiratory Syndrome- associated Coronavirus (MERS-CoV) disease
• Multi-system Inflammatory Syndrome in Children (MIS-C)
• Novel influenza A virus infections
• Orthopox virus infections (monkeypox, smallpox, vaccinia)
• Plague
• Poliomyelitis
• Rabies, animal or human
• Rubella
• Severe Acute Respiratory Syndrome- associated Coronavirus (SARS-CoV) disease
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (the virus that causes COVID-19)
• Tularemia
• Viral hemorrhagic fevers (due to Crimean- Congo Hemorrhagic Fever virus, Ebola virus, Lassa virus, Lujo virus, Marburg virus, New World arenaviruses)
• Yellow fever

• Arboviral diseases, neuroinvasive and non- neuroinvasive, including:
  1. California serogroup virus diseases, including diseases caused by:
     • California encephalitis virus;
     • Jamestown Canyon virus;
     • Keystone virus;
     • La Crosse virus;
     • Snowshoe hare virus; and
     • Trivittatus viruses;
  2. Chikungunya virus disease;
  3. Eastern equine encephalitis virus disease;
  4. Powassan virus disease;
  5. St. Louis encephalitis virus disease;
  6. Venezuelan equine encephalitis disease;
  7. West Nile virus disease;
  8. Western equine encephalitis virus disease;
  9. Zika virus disease or infection or the birth of a child to a mother who was Zika-positive or Zika-inconclusive during any stage of pregnancy or during the periconceptional period.
• Brucellosis (cases not temporally or spatially clustered)
• Campylobacteriosis
• Carbon monoxide poisoning
• Cholera
• Cryptosporidiosis
• Cyclosporiasis
• Dengue virus infections
• Escherichia coli O157:H7
• Foodborne disease outbreak
• Giardiasis
• Haemophilus influenzae invasive disease
• Hansen's disease (leprosy)
• Hantavirus infection, non-Hantavirus pulmonary syndrome
• Hantavirus pulmonary syndrome (HPS)
• Hemolytic uremic syndrome (HUS), post- diarrheal
• Hepatitis B, acute, infection in a pregnant woman; an infant or a child aged five (5) years or less, or newborns born to Hepatitis B positive mothers at the time of delivery
• Influenza-associated mortality
• Legionellosis
• Leptospirosis
• Listeriosis
• Mumps
• Norovirus outbreak
• Pertussis
• Pesticide-related illness, acute
• Psittacosis
• Q fever
• Rubella, congenital syndrome
• Salmonellosis
• Shiga toxin-producing E. coli (STEC)
• Shigellosis
• Streptococcal toxic-shock syndrome;
• Streptococcus pneumoniae, invasive disease
• Tetanus
• Toxic-shock syndrome (other than Streptococcal)
• Tuberculosis
• Typhoid fever
• Varicella
• Vibriosis
• Waterborne disease outbreak
   

• Acute Flaccid Myelitis
• Anaplasmosis
• Babesiosis
• Coccidioidomycosis
• Creutzfeldt-Jakob disease
• Ehrlichiosis
• Hepatitis C, acute, infection in a pregnant woman, infection in an infant or a child aged five (5) years or less, or newborns born to Hepatitis C positive mothers at the time of delivery
• Histoplasmosis
• Laboratory-confirmed influenza
• Lead poisoning
• Lyme Disease
• Malaria
• Spotted Fever Rickettsiosis (Rocky Mountain Spotted Fever)
• Toxoplasmosis
• Trichinellosis (Trichinosis)

Notification of the following diseases shall be considered routine and shall be electronically reported to the Kentucky Department for Public Health through the Kentucky Health Information Exchange within five (5) business days:

• Hepatitis B laboratory test results, whether reported as positive or negative:
  • Include the serum bilirubin levels taken within ten (10) days of the test of a patient who has tested positive; or
  • Include the serum alanine aminotransferase levels taken within ten (10) days of the test of a patient who tested positive.
• Hepatitis C laboratory test results, whether reported as positive or negative:
  • Include the serum bilirubin levels taken within ten (10) days of the test of a patient who has tested positive; or
  • Include the serum alanine aminotransferase levels taken within ten (10) days of the test of a patient who tested positive.
• Varicella laboratory test results reported as positive for:
  • Isolation of varicella virus from a clinical specimen;
  • Varicella antigen detected by direct fluorescent antibody test; or
  • Varicella-specific nucleic acid detected by polymerase chain reaction (PCR)